What is Medixall Group, Inc. (MDXL) stock price today?

Medixall Group, Inc. (MDXL) is currently trading at $0.01, up 0% today.

What is MDXL P/E ratio?

Medixall Group, Inc.'s P/E ratio is -0.15. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is MDXL return on equity (ROE)?

Medixall Group, Inc.'s return on equity (ROE) is 89.54%. ROE measures net income relative to shareholders' equity. Shareholders' equity is negative, so ROE is not a meaningful measure for this company.

What is Medixall Group, Inc.'s market cap?

Medixall Group, Inc. has a market capitalization of $1.15M.

OTC · Medical - Healthcare Information Services

Medixall Group, Inc. (MDXL) Stock

$0.01 +0.00% OTC: MDXL Healthcare

MediXall Group, Inc., together with its subsidiaries, provides health solutions in the United States. The company offers Health Karma platform that provides bundle healthcare and well-being services to individuals, employer groups, organizations, associations, resellers, and third-party administrators.

Valuation

Metric	Value
Price	$0.01
Market Cap	$1.15M
P/E Ratio	-0.15
P/B Ratio	-0.11
P/S Ratio	3.72
EPS (TTM)	$-0.04
52-Week High	$0.01
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	89.54%
ROA	—
ROCE	60.03%
Gross Margin	23.56%
Operating Margin	—
Net Margin	—
Debt/Equity	-0.59
Current Ratio	0.00

Annual Financials (USD)

Metric	2019	2020	2021	2022	2023
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-3.0M	$-6.0M	$-7.0M	$-7.0M	$-4.0M
Net Profit	$-3.0M	$-6.0M	$-6.0M	$-7.0M	$-5.0M
EPS	$-0.05	$-0.07	$-0.06	$-0.06	$-0.04
Op Margin	-127409.7%	—	-43561.3%	-11035.1%	-1265.6%

Balance Sheet (USD)

Metric	2019	2020	2021	2022	2023
Total Assets	$1.0M	$2.0M	$1.0M	$1.0M	$0
Total Liabilities	$1.0M	$1.0M	$1.0M	$5.0M	$7.0M
Cash	$0	$1.0M	$0	$0	$0
Borrowings	$0	$0	$0	$3.0M	$4.0M

Cash Flow (USD)

Metric	2019	2020	2021	2022	2023
Operating Cash Flow	$-2.0M	$-4.0M	$-5.0M	$-4.0M	$-1.0M
Investing Cash Flow	$0	$-1.0M	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$0	$-1.0M	$0	$0
Free Cash Flow	$-2.0M	$-4.0M	$-5.0M	$-4.0M	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-1.28
FCF Yield	-106.84%
Quick Ratio	0.00
Interest Coverage	-6.05
Return 1Y	43.59%
Return 3Y	522.22%
Return 5Y	—

Ownership

Insiders Held8.72%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ABMTAdvanced BioMedical Technologies Inc.	$0.00	—	-0.07	$50000	0.00%
FIORFFiore Cannabis Ltd.	$0.00	—	0.00	$1971	0.00%
HSMDHealthcare Solutions Management Group, Inc.	$0.00	—	0.00	$18443	0.00%
MRRCFWayland Group Corp.	$0.00	—	0.00	$2121	0.00%
NHELNatural Health Farm Holdings Inc.	$0.00	—	-0.01	$16219	0.00%

About Medixall Group, Inc.

Medixall Group, Inc. is headquartered in US.

Medixall Group, Inc. (MDXL) stock trades at $0.01 with a market capitalization of $1.15M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.15, reflecting a net loss over the last twelve months, a negative price-to-book of -0.11, reflecting negative shareholders' equity, price-to-sales of 3.72. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades at or near its 52-week high.

On profitability, Medixall Group, Inc. generates a return on equity (ROE) of 89.54% (not meaningful, as shareholders' equity is negative), return on capital employed of 60.03%.

Official website: www.healthkarmagroup.com